Skip to main content
American Journal of Respiratory and Critical Care Medicine logoLink to American Journal of Respiratory and Critical Care Medicine
letter
. 2023 Jun 22;208(5):630–631. doi: 10.1164/rccm.202303-0366LE

The Potential Role of Gastric Microbiology in Respiratory Disease

Chris Ward 1,2,, Hafez Al Momani 1,2,3, Melissa J McDonnell 4, Desmond M Murphy 5,6,7, Laura Walsh 5,6,7, John Mac Sharry 6,7, Mike Griffin 8, Ian A Forrest 9, Rhys Jones 10, Amaran Krishnan 11, Jeffrey Pearson 1,2, Robert M Rutherford 4
PMCID: PMC10492259  PMID: 37348122

To the Editor:

We read with interest the study from Narayana and colleagues documenting a dysregulated gut-lung axis in bronchiectasis in sputum and stool sample microbiota (1). This described a novel clinical phenotype, featuring a “high gut-lung interaction” cluster characterized by lung Pseudomonas (Pa), and gut Bacteroides and Saccharomyces, with associated increased exacerbations. Both the paper and the accompanying editorial highlighted that coordinated sampling of gastrointestinal and lung compartments provided novel complementary information. The editorial cited this as “the first human study of any respiratory condition to integrate analysis of microbiota across both anatomic compartments” (p. 812) (2). We congratulate the authors for undertaking this complex adult study. Previous work by Gallacher and colleagues (3), which showed dissimilarity of the gut-lung axis and dysbiosis of the lower airways in ventilated preterm infants, emphasizes the broad ranging scope of gut-lung studies (1, 39).

We feel that a discussion of sampling strategies may be timely for future research, and our previous work including longitudinal microbiome analyses of gastric juice and lung samples (7) could be relevant. We showed strains of Pa and nontuberculosis mycobacteria in gastric and sputum samples from people with cystic fibrosis with symptoms of extraesophageal reflux. Molecular techniques, including sequencing, confirmed that gastric and lung organisms were clonally related, and Pa and nontuberculosis mycobacteria were sometimes identified in gastric samples, but not in lung samples, indicating a possible gastric reservoir of microorganisms. Our work is potentially consistent with a complex, direct, bidirectional interplay, from lung to gut and gut to lung, in chronic suppurative airway disease.

It is underappreciated that a degree of microaspiration, including metabolically active microbiota, may be physiological and homeostatic, with disruption in lung disease (7, 8). In bronchiectasis, gastroesophageal reflux disease, a potential precursor to aspiration, ranges from 34% to 74%, and asymptomatic reflux is documented in 42–73% of patients (5). Three large prospective studies associate gastroesophageal reflux disease with increased bronchiectasis symptoms, exacerbations, and hospitalizations. Increased mortality has been described in a single-center, 212-patient study and a multicenter study of 986 patients (5, 6).

We postulate that increased microaspiration of gastric content may be consistent with airway and lung injury. In patients with hypochlorhydria who were treated for symptoms of reflux with acid-suppressing medications (47), gastric content can include metabolically active, viable microbiota (7). Our proposed interactions of the gastric and lung compartment potentially fit ecology-model explanations of microbial species present in the respiratory system, with diverse immigration and extinction factors at play, including direct microaspiration (8, 9).

Narayana and colleagues (1) discussed that the “low percentage of bacterial versus fungal overlap between the gut and lung does suggest that direct microbial interaction between sites is less likely” (p. 915). We wonder whether one potential explanation of our varied interpretations is that gut microbiome analyses are commonly predicated on the use of stool samples, influenced by the large intestine, whereas few data exist from gastric samples? Fecal samples are valuable and accessible, and they have informed studies of the microbiome. We have also found that paired, contemporaneous gastric secretion and lung samples provide insights. Gastric secretions are routinely discarded during endoscopy and ethics review boards, and patients are broadly supportive of interdisciplinary translational research. We suggest that future research could benefit from a discussion of a recommended panel of biological samples that could inform future studies of gut-lung interaction in chronic lung disease, including bronchiectasis.

Footnotes

Originally Published in Press as DOI: 10.1164/rccm.202303-0366LE on June 22, 2023

Author disclosures are available with the text of this letter at www.atsjournals.org.

References

  • 1. Narayana JK, Aliberti S, Mac Aogáin M, Jaggi TK, Ali NABM, Ivan FX, et al. Microbial dysregulation of the gut-lung axis in bronchiectasis. Am J Respir Crit Care Med . 2023;207:908–920. doi: 10.1164/rccm.202205-0893OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Drohan CM, Molyneaux PL, Dickson RP. How to understand a revolution: guts, lungs, and bronchiectasis. Am J Respir Crit Care Med . 2023;207:812–814. doi: 10.1164/rccm.202211-2179ED. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Gallacher D, Mitchell E, Alber D, Wach R, Klein N, Marchesi JR, et al. Dissimilarity of the gut-lung axis and dysbiosis of the lower airways in ventilated preterm infants. Eur Respir J . 2020;55:1901909. doi: 10.1183/13993003.01909-2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Sullivan A, Hunt E, MacSharry J, Murphy DM. ‘The microbiome and the pathophysiology of asthma.’. Respir Res . 2016;17:163. doi: 10.1186/s12931-016-0479-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. McDonnell MJ, Hunt EB, Ward C, Pearson JP, O’Toole D, Laffey JG, et al. Current therapies for gastro-oesophageal reflux in the setting of chronic lung disease: state of the art review. ERJ Open Res . 2020;6:00190-2019. doi: 10.1183/23120541.00190-2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. McDonnell MJ, Aliberti S, Goeminne PC, Restrepo MI, Finch S, Pesci A, et al. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. Lancet Respir Med . 2016;4:969–979. doi: 10.1016/S2213-2600(16)30320-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Al-Momani H, Perry A, Nelson A, Stewart CJ, Jones R, Krishnan A, et al. Exposure to bile and gastric juice can impact the aerodigestive microbiome in people with cystic fibrosis. Sci Rep . 2022;12:11114. doi: 10.1038/s41598-022-15375-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Mac Aogáin M, Baker JM, Dickson RP. On bugs and blowholes: why is aspiration the rule, not the exception? Am J Respir Crit Care Med . 2021;203:1049–1051. doi: 10.1164/rccm.202011-4257ED. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Dickson RP, Erb-Downward JR, Huffnagle GB. Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis. Lancet Respir Med . 2014;2:238–246. doi: 10.1016/S2213-2600(14)70028-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Respiratory and Critical Care Medicine are provided here courtesy of American Thoracic Society

RESOURCES